Surgery Archives - InnoHEALTH magazine

8 Top Healthcare Innovations

InnoHEALTH Magazine — Thu, 21 Nov 2019 11:25:56 +0000

1. Akiva Superfoods Raises $2 Million

Akiva superfoods, a company that offers health and wellness food products recently raised $ 2 million funding led by Alkemi Venture partners which mainly invests in healthcare and consumer products. The mission of Akiva, as implied by its Founder and CEO Shalabh Gupta, is to aid people to bring about significant changes to their lifestyle and food habits, to live a better and healthier life. Akiva Superfoods is data-rich, close to its clients and uses significant ideas to create products to scale with direct-to-consumer, e-commerce, and latest business channels. With the funding so raised, now the company intends to be a more innovative, exciting and independent FMCG company with a capacity to scale exponentially across tier-1 and tier-2 cities in India. CEO of Max Healthcare Rajit Mehta, Co-founder of Zomato Pankaj Chaddah, CEO of OYO Real Estate Rohit Kapoor, Co-founder of MindTickle Mohit Garg are some of the previous investors in Akiva. Source: www.inshorts.com

2. Pencil Beam Technology for Cancer

India has a huge number of cancer patients, keeping them in mind Apollo Group has launched Asia’s first proton therapy centre known as Apollo Proton Cancer Centre (APCC) located in Taramani, Tamil Nadu, India. Proton therapy is one of the most advanced forms of radiation treatment which attacks tumours with more precision thereby causing minimal damage to the surrounding healthy tissues. This therapy is particularly effective for pediatric cancers; tumours affecting eye, brain, breast, colon, gastrointestinal region, prostate and pelvis; areas close to the spinal cord, brain stem and other vital organs; and re-radiation in relapsed cases. Proton therapy is particularly useful in curing paediatric cancers. The centre built at a cost of Rs 1300 crore will cater not only to Indian patients but also a destination for foreign patients promoting Medical Tourism for cancer treatment. With this step taken by the Apollo hospitals, India becomes one of the few nations which offers proton therapy for cancer treatment in addition to UK. The facility is 150 bedded dedicated to cancer care with three proton therapy rooms, advanced radiation oncology centre, medical oncology and immuno therapy facility and high end day-care chemo wards. The facility will also have five modular digital MRI integrated operation theatres, besides a high-end diagnostic imaging centre for genomic profiling of cancers including DNA sequencing and digital pathology services. SOURCE: www.healthtechnology.in

3. Bio Glue for Fast Wound Repairing

Any trauma or surgery can lead to uncontrolled bleeding which is a major cause of death many a times as it is difficult to seal these bleeding wounds without sutures. To tackle this problem, a team of researchers in China from Zhejiang University and East China University of Science and Technology have developed a ‘biological glue’ that could one day stop arteries and hearts from uncontrollable bleeding. The study is published online in the Journal Nature Communications. So far, the use of the gel has been demonstrated in animal experiments involving pigs and rabbits wherein the light activated adhesive gel can rapidly seal wounds to arteries and the heart and could be potentially used in surgeries in the future. The USP of the biological gel is that when it is placed on an open wound, it mimics the composition of the extracellular matrix and sets fast when exposed to ultraviolet light. The non-toxic hydrogel can be injected and has the potential to be used for surgical haemostasis and fast wound sealing in cases of open surgery and minimally invasive endoscopic surgery. The gel is also capable of withstanding both slippery surfaces and the pulsing of heart tissue. The adhesive gel still has not been used on human organs, but a prototype was used inside rabbits and pigs where it performed better than sutures or other currently available surgical glues. In preliminary animal experiments, a set of surgical procedures were carried out on pigs and the use of gel could seal the wounds of livers of pigs without the need for sutures. With the use of this gel, for the first time ever high-pressure bleeding of a beating heart with 6 mm diameter cardiac penetration holes, was stopped and the wounds were stably sealed within 20 seconds without sutures. In pig surgery, the gel closed a punctured carotid artery in less than a minute and repaired a hole in the cardiac wall. In rabbit surgery, the light activated hydrogel was able to stop a bleeding liver cut and a femoral artery in mere seconds. The three pigs not only survived the heart surgery but also showed natural signs of healing within 2 weeks with little inflammation and almost no necrosis. Despite the progress, additional studies are needed to confirm the safety of the gel for its use in further trials, including those involving humans. The gel has improved properties over other similar materials present in the market – it can withstand upto 290 mmHg blood pressure, which is much higher than what most doctors and nurses usually deal with, it’s structure is based on that of human connective tissue, the extracellular matrix of this gel is compatible with internal organs and arteries that facilitates it’s binding with arterial and cardiac walls. The team is hoping that the gel could be ready for human surgical use in the next 3 to 5 years.

SOURCE: www.sciencealert.com

4. Bluestar Diabetes

The International Diabetes Foundation has predicted that diabetes could affect nearly 123 million of the Indian population by 2040 and world over the treatment for diabetes complications costs more than $670 billion dollars a year. The disease claims the lives of five million people worldwide each year. To contribute to the efficient management of diabetes, IFC (a member of the World Bank Group), WellDoc (a US-based digital health start-up) and Max Healthcare (a leading healthcare provider in India) have come together and recently launched an innovative mobile application named ‘Bluestar Diabetes’ to improve diabetic care in India. The pilot project will include a selected group of patients in New Delhi whose smart phones, personal computers and tablets will transform into a personal health advisor once the app is downloaded on their devices. The app will be tailored for the Indian market to account for local diets and specific medications which will allow patients to enter details of their meals and receive immediate advice on optimal medication and dosage. The app by WellDoc is a mobile health monitoring tool that helps type 2 diabetes patients and their doctors drive behavioural and clinical change by analyzing the diabetes data including medications and blood glucose levels entered by the patient which is then shared with the patient’s healthcare team to improve decisions and better manage the disease. IFC is providing the funding and support through its TechEmerge program which works in the emerging markets to match innovative firms with local partners creating a win-win situation for businesses. This TechEmerge program is being implemented in partnership with the Finnish Ministry of Employment and Economy along with the Israeli Ministry of Economy and Industry, and supported by Indian Health 2.0. The focus of Max Healthcare is on changing the healthcare delivery to serve patients with chronic ailments of which one is diabetes in a better and more efficient way. Thus, the role of each partner comes from their own vision and areas of expertise. Hope to witness better management of diabetes care in India with this initiative of the parties.

SOURCE: www.healthtechnology.in

5. ‘SCGEN’ – AN AI Tool to Predict Cell Behaviour

Researchers have created an Artificial Intelligence powered tool named ‘scGen’ that promises to reshape the way we study diseases and their treatment at cellular level. The research is published in the Journal Nature Methods where it demonstrates that scGen will help to map and study cellular disease response and treatment beyond the information accessible from experiments. scGen is the first tool to predict out-of-sample cellular reaction which means it is prepared to create credible projections for a distinct system if trained on information capturing the impact of perturbations for a specified system. As per scientists, scGen is a generative deep learning model that takes ideas from pictures, sequence and language processing and then uses them to model a cell’s behaviour conducted on a computer or through computer simulation. scGen is a part of computational biology which has the objective to accurately model cellular response to perturbations like illness, genetic procedures. The team further needs to work to make it a fully data driven formulation so that its predictive power is enhanced, and it permits better and more accurate analysis of perturbation combinations. SOURCE: www.healthtechnology.in

6. Artificial Intelligence may soon help spot Autism early on

It is difficult to identify signs and symptoms of autism in kids, but a recent study released in the Journal Proceedings of the National Academy of Sciences indicates that easy quantifiable artificial intelligence measures could allow for much earlier diagnosis of Rett syndrome and potentially other autism-like illnesses. Rett syndrome is a genetic disorder that impairs sensory, motor, cognitive and autonomic function from 6 to 18 months of age. The research has revealed that a machine-learning algorithm can detect pupil dilation defects that can predict autism spectrum disorder (ASD) in mouse models. In the research, the algorithm has shown to detect correctly if a child has Rett syndrome and autism-like behavior. Researchers hope that this algorithm will be able to provide an early warning signal not only for Rett syndrome but also for ASD. The team thinks that this tool can further be used in the future to monitor the reactions of patients to medicines as currently, it is testing the drug ketamine for Rett syndrome and a gene therapy trial is also in works. SOURCE: www.healthtechnology.in

7. Care4u: An Artificial Intelligence App for Geriatric Care

Second year students of B.Tech, IIT Kharagpur recently created an interconnected android smartphone application ‘CARE4U’ to promote elderly care by helping caregivers reach the elderly on time. To connect both the parties, CARE4U is mounted both on the elderly’s devices and the caregiver’s smartphone. The neural network based drop detection algorithm in the app on the elderly’s phone can identify whether the elderly has fallen down. In case of a fall, it automatically calls the caregiver and emergency services along with the location of the elderly. A unique feature of the app is that it detects emotion of the person by taking his/her picture and calculating their index of mood. To make this feature more effective, the team has developed a cognitive intelligent chat bot for better engagement of the elderly. Other features of the app include operations like calling, booking a taxi, sending a message, medical history record, an SOS button, an allergy account, real-time location monitoring and medicine reminder which reminds both the elderly and the caregiver the time of taking the medicine. SOURCE: www.healthtechnology.in

8. Itc Lamp: Hemorrhage Control Device

Massive hemorrhage is the leading cause of death in traumatic injuries, immediate control of bleeding is of prime importance in such scenarios. With a vision to effectively contain such situations of traumatic injuries a firm, Innovative Trauma Care (ITC) came into action. ITC, a Canada based early-stage medical device firm, focuses on developing point of care solutions for trauma, first responders and military medicine applications. With this vision, they introduced iTClamp, a hemorrhage control device for use in the extremities, axilla, inguinal, scalp and neck. The device minimizes blood loss until the wound is surgically repaired by sealing the edges of the wound. Research studies have shown that the clamp is superior to wound packing in terms of patient survival, survival time and total blood loss. iTClamp hemorrhage control system is one of the most unique devices and ideal for emergency medical personnel as it is simple to use, does an immediate fluid-tight and airtight wound closure within seconds. The clamping device works by sealing the skin closed to create a temporary pool of blood under pressure, which forms a stable clot until surgical repair of the wound is done. The device has been in the market for a while now and is a hit amongst the emergency first responders. The company is trying to address the unmet needs in the emergency medicine field by developing, manufacturing and commercialising point of injury solutions to control the common causes of preventable death in traumatic injury situations. SOURCE: www.innovativecare.com

Healthcare Newscope

Compiled by Dr. Avantika Batish, working as the Director Strategy and Healthcare at International Health Emergency Learning and Preparedness. She is also a guest faculty for MBA (HR) and MBA Healthcare Management at various B-Schools and is a soft skills trainer.

The post 8 Top Healthcare Innovations appeared first on InnoHEALTH magazine.

Aspirin to Aspiration

InnoHEALTH Magazine — Wed, 21 Nov 2018 05:55:29 +0000

3 Facts that pushed an industry from ASPIRIN to ASPIRATION

How technology and innovation will drive the Pharma industry? Ever since the pyramids were erected in Giza, the need for medication and surgery were required. During the Stone Age, as early as 3,300 BC, studies have shown that primitive forms of herbal condiments were used to treat wounds and certain lung disorders. Ayurveda, from the annals of the Hindu Veda scriptures, can be traced back to almost 4,000 BC.

The first institution to train individuals in the field of physiology and medication was established in Italy, around the 15th century.

Although the first landmark in the healthcare industry was the accidental discovery of Penicillin by Scottish scientist Alexander Fleming, in the year 1928; the widespread use of Penicillin was initiated only in 1942 to treat infections caused by Streptococci Bacterium. But over time, Penicillin-resistant bacteria began to come to life.

[vc_single_image image=”4904″ img_size=”300×250″ alignment=”center” onclick=”link_image”]

And it wasn’t an isolated situation, as overtime viruses and parasites begun mutating and developing resistance over their target medication that it became important to continuously develop more advanced strains of medicines, and this sparked off the birth of the Pharmaceutical and Drug testing industry!

In 2018, the pharmaceutical industry is one of the top 3 industries in the world. In 2017, the pharmaceutical industry pumped nearly USD 24 bill into advertising and PR, with USD 12 bill from the United States alone!

The industry invests nearly USD 40 bill a year on drug development and clinical trials, making it one of the biggest contributors to the international economy.

The need for constant innovation and development of drugs has risen drastically over the last 15 years. The growth spurt arose due to the birth of certain strains of bacterium and viruses that have begun adapting to the medication. As the causal organisms began to adapt to the quintessential drugs, the industry had to keep researching drugs to fight this mutation.

(By Trescon)

The post Aspirin to Aspiration appeared first on InnoHEALTH magazine.

Low back pain is the leading cause of disability

InnoHEALTH Magazine — Thu, 18 Oct 2018 06:26:22 +0000

Affecting an estimated 540 million people at any one time, but unfortunately, the condition is mistreated against the best-known guidelines. Worldwide, overuse of inappropriate tests and treatments such as imaging, opioids, and surgery means patients are not receiving the right care, and resources are wasted.

Evidence suggests that low back pain should be managed in primary care, with the first line of treatment being education and advice to keep active at work.

A 2008 survey of all registered physiotherapists in Maharashtra (India) showed that 46 percent of physiotherapists advised patients with low back pain to rest.

63 percent of Indians believe that bed rest is the mainstay of therapy.

A new series of papers in The LANCET highlights the extent to which the condition is wronged, often against best practice treatment guidelines.

[vc_single_image image=”4697″ img_size=”400×400″ alignment=”center” onclick=”link_image”]

According to researchers a prospective study in the period 10th October 2008 of 25251 patients with chronic back pain received in an Indian orthopedic clinic, reported that 100 percent of patients underwent imaging, with 76 % diagnosed with non-specific low back pain and 10 % with spondylosis. According to the Global Burden of Disease study every year, a total of 7.3 million years of productive life is lost in India because of disability from low back pain. Physiotherapist and Assistant Professor Saurabh Sharma, in the Department of Physiotherapy, Kathmandu University of Medical Sciences, told InnoHEALTH magazine in an email interview that he was also aware of practices of low back pain, which is far away from evidence recommendations.” For example, rest, lumbar supports/corsets are prescribed very commonly against the current recommendations.

Also Read: Cybersecurity Bootcamp for Hospitals

Similarly, all patients are prescribed medicines, electrotherapy, taping, and ex-rays. More than half individuals are advised MRI. Similarly, patients are also treated with new treatments that the clinicians claim but have never been tested in clinical trials (research), such as matrix rhythm theory practice in Pune, he said. In reality, a high proportion of patients worldwide are treated in emergency departments, encouraged to rest and stop work, are commonly referred for scans or surgery or prescribed painkillers including opioids, which are discouraged for treating low back pain.

“The majority of cases of low back pain respond to simple physical and psychological therapies that keep people active and enable them to stay at work,” explains series author Professor Rachelle Buchbinder, Monash University, Australia. “Often, however, it is more aggressive treatments of dubious benefit that are promoted and reimbursed.”

The series reviews evidence from high-and low-income countries that suggests that many of the mistakes of high-income countries are already well established in low-income and middle-income countries. Rest is frequently recommended in low and middle-income countries, and resources to modify workplaces are scarce.

Low back pain results in 2.6 million emergency visits in the USA each year, with high rates of opioid prescription. A 2009 study found that opioids were prescribed to around 60% of emergency department visits for low back pain in the USA. Additionally, only about half of people with chronic back pain in the USA have been prescribed exercise. In India, studies suggest that bed rest is frequently recommended, and a study in South Africa found that 90% of patients received pain medicine as their only form of treatment.

“In many countries, painkillers that have limited positive effect are routinely prescribed for low back pain, with very little emphasis on interventions that are evidence-based such as exercises. As lower-income countries respond to this rapidly rising cause of disability, it is critical that they avoid the waste that these misguided practices entail,” adds series author Professor Nadine Foster, Keele University, UK.

The Global Burden of Disease study (2017) found that low back pain is the leading cause of disability in almost all high-income countries as well as central Europe, Eastern Europe, North Africa, and the Middle East, and parts of Latin America. Every year, a total of 1 million years of productive life is lost in the UK because of disability from low back pain; 3 million in the USA; and 300,000 in Australia (see GBD for country-specific estimates available).

Low back pain mostly affects adults of working age. Rarely can a specific cause of low back pain be identified so most are termed nonspecific and evidence suggests that psychological and economic factors are important in the persistence of low back pain? Most episodes of low back pain are short-lasting with little or no consequence, but recurrent episodes are common (about one in three people will have a recurrence within 1 year of recovering from a previous episode) and low back pain is increasingly understood as a long-lasting condition.

[vc_single_image image=”4704″ img_size=”390×280″ alignment=”center” onclick=”link_image”]

The authors say that healthcare systems should avoid harmful and useless treatments by only offering treatments in public reimbursement packages if evidence shows that they are safe, efficient and cost-effective. They also highlight the need to address widespread misconceptions in the population and among health professionals about the causes, prognosis, and effectiveness of different treatments for low back pain.

“Millions of people across the world are getting the wrong care for low back pain. Protection of the public from unproven or harmful approaches to managing low back pain requires that governments and health-care leaders tackle entrenched and counterproductive reimbursement strategies, vested interests, and financial and professional incentives that maintain the status quo,” says series author Prof. Jan Hartvigsen, University of Southern Denmark. “Funders should pay only for high-value care, stop funding ineffective or harmful tests and treatments, and importantly intensify research into prevention, better tests, and better treatments.”

The post Low back pain is the leading cause of disability appeared first on InnoHEALTH magazine.

INDIA EXPLORES NEW DESTINATIONS FOR MEDICAL TOURISM

InnoHEALTH Magazine — Thu, 17 Aug 2017 07:28:09 +0000

Medical tourism is a growing sector in India. In October 2015, India’s medical tourism sector was estimated to be worth US$3 billion. It is projected to grow to $7–8 billion by 2020. According to the Confederation of Indian Industries (CII), the primary reason that attracts medical value travel to India is cost-effectiveness, and treatment from accredited facilities at par with developed countries at much lower cost. The Medical Tourism Market Report: 2015 found that India was “one of the lowest cost and highest quality of all medical tourism destinations, it offers wide variety of procedures at about one-tenth the cost of similar procedures in the United States.”

Foreign patients travelling to India to seek medical treatment in 2012, 2013 and 2014 numbered 171,021, 236,898, and 184,298 respectively. Traditionally, the United States and the United Kingdom have been the largest source countries for medical tourism to India. However, according to a CII-Grant Thornton report released in October 2015, Bangladeshis and Afghans accounted for 34% of foreign patients, the maximum share, primarily due to their close proximity with India and poor healthcare infrastructure. Russia and the Commonwealth of Independent States (CIS) accounted for 30 percent share of foreign medical tourist arrivals. Other major sources of patients include Africa and the Middle East, particularly the Persian Gulf countries. In 2015, India became the top destination for Russians seeking medical treatment. Chennai, Kolkata, Mumbai, Hyderabad, Bangalore and the National Capital Region received the highest number of foreign patients primarily from South Eastern countries.

[vc_empty_space]

[vc_single_image image=”1947″ img_size=”451×282″ alignment=”center” onclick=”link_image” qode_css_animation=””]

[vc_empty_space]

Attractions

Advantages of medical treatment in India include reduced costs, the availability of latest medical technologies, and a growing compliance on international quality standards, Doctors trained in western countries including US and UK, as well as English-speaking personnel, due to which foreigners are less likely to face language barrier in India. According to the Confederation of Indian Industries (CII), the primary reason that attracts medical value travel to India is cost-effectiveness, and treatment from accredited facilities at par with developed countries at much lower cost. The Medical Tourism Market Report: 2015 found that India was “one of the lowest cost and highest quality of all medical tourism destinations, it offers wide variety of procedures at about one-tenth the cost of similar procedures in the United States.”

Cost

Most estimates found that treatment costs in India start at around one-tenth of the price of comparable treatment in the United States or the United Kingdom. The most popular treatments sought in India by medical tourists are alternative medicine, bone-marrow transplant, cardiac bypass, eye surgery and hip replacement. India is known in particular for heart surgery, hip resurfacing and other areas of advanced medicine.

Quality of care

India has 28 Joint Commission International (JCI) accredited hospitals. However, for a patient traveling to India, it is important to find the optimal Doctor-Hospital combination. After the patient has been treated, the patient has the option of either recuperating in the hospital or at a paid accommodation nearby. Many hospitals also give the option of continuing the treatment through tele-medicine.

The city of Chennai has been termed “India’s health capital”. Multi and super-specialty hospitals across the city bring in an estimated 150 international patients every day. Chennai attracts about 45 percent of health tourists from abroad arriving in the country and 30 to 40 per cent of domestic health tourists.

Factors behind the tourist inflow in the city include low costs, little to no waiting period, and facilities offered at the specialty hospitals in the city. Chennai has an estimated 12,500 hospital beds, of which only half is used by the city’s population with the rest being shared by patients from other states of the country and foreigners. Dental clinics have attracted dental care tourism to Chennai.

Ease of travel

The government has removed visa restrictions on tourist visas that required a two-month gap between consecutive visits for people from Gulf countries which is likely to boost medical tourism. A visa-onarrival scheme for tourists from select countries has been instituted which allows foreign nationals to stay in India for 30 days for medical reasons. In 2016, citizens of Bangladesh, Afghanistan, Maldives, Republic of Korea and Nigeria availed the most medical visas.

Language

Despite India’s diversity of languages, English is an official language and is widely spoken by most people and almost universally by medical professionals. In Noida, which is fast emerging as a hotspot for medical tourism, a number of hospitals have hired language translators to make patients from Balkan and African countries feel more comfortable while at the same time helping in the facilitation of their treatment.

[vc_empty_space]

Want to write for InnoHEALTH? send us your article at magazine@innovatiocuris.com

[vc_empty_space]

Read all the issues of InnoHEALTH magazine:
InnoHEALTH Volume 2 Issue 3 (July to September 2017) – https://goo.gl/MCVjd6
InnoHEALTH Volume 2 Issue 2 (April to June 2017) – https://goo.gl/Nv3eev
InnoHEALTH Volume 1 Issue 2 (October to December 2016) – https://goo.gl/4GGMJz
InnoHEALTH Volume 1 Issue 1 (July to September 2016) – https://goo.gl/iWAwN2

[vc_separator type=”normal”]

Connect with InnovatioCuris on:
Facebook: https://www.facebook.com/innovatiocuris
Twitter: https://twitter.com/innovatiocuris
Linkedin: https://www.linkedin.com/groups/7043791
Stay update about IC by visiting: www.innovatiocuris.com

Connect with InnoHEALTH 2017 on:
Facebook: https://www.facebook.com/innohealth2017
Twitter: https://twitter.com/innhealth2017
Linkedin: https://www.linkedin.com/groups/7043791
Stay update about the conference by visiting: www.innohealth.in

The post INDIA EXPLORES NEW DESTINATIONS FOR MEDICAL TOURISM appeared first on InnoHEALTH magazine.

PRACTO INTRODUCED PRACTO RAY TAB

InnoHEALTH Magazine — Mon, 24 Jul 2017 07:39:49 +0000

[vc_single_image image=”944″ img_size=”146×200″ onclick=”link_image” qode_css_animation=””]

PRACTO RAY TAB Introduces Digital Consent Forms for the first time in India
Dr. Avantika Batish is working as Director Strategy and Healthcare at International Health Emergency Learning and Preparedness. Also, guest faculty for MBA (HR) and MBA Healthcare Management at various B-Schools and is a soft skills trainer.

[vc_empty_space]

For the very first time consent forms have been given the digital makeover. Practo, the leading digital healthcare platform has announced the integration of consent forms into the Practo Ray Tab for the first time. Available across general, dental, dermatology and gynaecology practices; the integration is aimed to further digitise practice management and ensure that patients sign the form before they undergo any treatment or surgery.

Clinics can customise the form as per their needs and create different consent forms based on different treatments.

In June, 2014 Practo Tab was built to serve as a seamless companion for Practo Ray- the widely- used practice management and appointment scheduling software for doctors and clinics. Practo Tab is an all-in-one device empowering practice management and enhancing patient relationship management.

The digital consent form will further strengthen the existing portfolio of services that are being offered on Practo Tab including patient registration, feedback, schedule management, billing etc. and help doctors manage their clinic from anywhere as all information is available on the cloud and accessible offline as well as online.

The digital consent forms available on Practo Tab are legally compliant and uses electronic signatures as per Sec 2 (ta) of Information Technology Act 2000. With the integration of consent form on Practo Tab, we will be able to provide better tools to doctors and significantly improve patient’s healthcare experience.

[vc_empty_space]

Want to write for InnoHEALTH? send us your article at magazine@innovatiocuris.com

[vc_separator type=”normal”]

The post PRACTO INTRODUCED PRACTO RAY TAB appeared first on InnoHEALTH magazine.